Method of purifying pluripotent vascular progenitor cells from perinatal tissue
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 至仁生命科技(天津)有限公司
- Publication Date
- 2021-01-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biomedical research, in particular to a method for purifying and obtaining multipotent vascular progenitor cells from perinatal tissues. Background technique
[0002] Perinatal tissue refers to the accessory organs and tissues related to fetal development produced during the period from 28 weeks of pregnancy to the birth of the baby, mainly including cord blood, umbilical cord and placenta. The perinatal tissue after the fetus is delivered at full term has a small chronological age and a low gene mutation rate. It is usually discarded as biological waste and can be obtained without any risk to the fetus and mother. The acquisition method will not cause harm to the human body, etc. advantage. Perinatal tissue has become the focus of attention in the field of regenerative medicine because it contains a variety of stem cells and specific tissue progenitor cell subsets, and has many advantages such as abundant resourc...